Table 5.
Trial | Phase | Setting | Regimen | Patients (n) | OS (mo) | PFS (mo) |
NCT00985192[137], 2010 | II | Advanced | Eve | 53 | 10.1 | 2.7 |
NCT00879333[138], 2013 | III | Advanced | Eve + BSC | 656 | 5.4 | 1.7 |
BSC | 4.3 | 1.4 | ||||
NCT01248403[139], Ongoing | III | Advanced | Eve + PTX | 480 | - | - |
PTX |
Eve: Everolimus; PTX: Paclitaxel; OS: Overall survival; PFS: Progression free survival.